Radnet, Inc. income statement
In fiscal 2025, Radnet, Inc. reported revenue of $2.04bn, up 11.5% on the year before, operating income of $62.0m (a 3.0% margin) and net income of −$18.7m, or −$0.25 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 528 | 552 | 585 | 647 | 703 | 718 | 810 | 885 | 922 | 975 | 1,154 | 1,072 | 1,315 | 1,430 | 1,617 | 1,830 | 2,040 | 2,269 |
| Cost of revenue | 398 | 31 | 32 | 38 | 38 | 37 | 708 | 776 | 802 | 868 | 1,000 | — | — | — | — | — | — | — |
| Gross profit | 130 | 521 | 554 | 609 | 665 | 681 | 101 | 109 | 120 | 108 | 154 | — | — | — | — | — | — | — |
| Operating income | 42 | 9 | 8 | 13 | 12 | 11 | 39 | 38 | 50 | 31 | 70 | 36 | 83 | 46 | 99 | 105 | 62 | 71 |
| Interest expense | 50 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 41 | 43 | 48 | 46 | 49 | 51 | 64 | 80 | 70 | 71 |
| Income before tax | −7 | −17 | 8 | 4 | 6 | 4 | 15 | 12 | 26 | 39 | 30 | −1 | 59 | 43 | 39 | 45 | 32 | 35 |
| Income tax | 0 | 1 | 1 | −55 | 4 | 2 | 6 | 4 | 24 | 0 | 6 | 1 | 15 | 9 | 8 | 6 | 15 | 16 |
| Net income | −2 | 8 | 8 | 12 | 12 | 11 | 8 | 7 | 0 | 32 | 15 | −15 | 25 | 11 | 3 | 3 | −19 | −21 |
| Diluted EPS | −$0.06 | −$0.35 | $0.19 | $1.52 | $0.05 | $0.03 | $0.17 | $0.15 | $0.00 | $0.66 | $0.29 | −$0.29 | $0.46 | $0.17 | $0.05 | $0.04 | −$0.25 | −$0.28 |
| Diluted shares (average) | 36m | 37m | 39m | 39m | 40m | 43m | 45m | 47m | 47m | 49m | 50m | 51m | 53m | 57m | 65m | 75m | 75m | 77m |
| EBITDA | 96 | 13 | 12 | 17 | 16 | 15 | 100 | 105 | 117 | 104 | 150 | 122 | 179 | 162 | 227 | 242 | 214 | 242 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 461 | 477 | 471 | 498 | 523 | 548 | 576 | 623 |
| Operating income | 34 | 25 | −24 | 31 | 27 | 28 | −24 | 39 |
| Interest expense | 19 | 18 | 17 | 17 | 17 | 18 | 18 | 18 |
| Income before tax | 17 | 15 | −33 | 24 | 20 | 21 | −33 | 27 |
| Income tax | 4 | 1 | −3 | 1 | 6 | 11 | −8 | 6 |
| Net income | 3 | 5 | −38 | 14 | 5 | −1 | −33 | 8 |
| Diluted EPS | $0.04 | $0.08 | −$0.51 | $0.19 | $0.07 | −$0.01 | −$0.43 | $0.10 |
| EBITDA | 69 | 61 | 11 | 67 | 67 | 69 | 21 | 85 |
Compare with peers
- Privia Health Group, Inc. income statement
- Evolent Health, Inc. income statement
- Hims & Hers Health, Inc. income statement
- Aveanna Healthcare Holdings, Inc. income statement
- Chemed Corp income statement
Head to head: PRVA vs RDNTEVH vs RDNTHIMS vs RDNT
More: Health Care Services stocks compared, Health Care sector, rankings of US companies